Brucellosis

NOTICE: DO NOT read this if you are offended by explicit language. Steel Panther has created a world of its own. Over the course of five studio albums since 2009, the band has honed the art of virtuosic throwback heavy metal but also laced it with lewd and lascivious bits of slapstick and ruthless self-deprecation. While the band built its aesthetic around the lovable clichés of '80s glam rock music videos, Steel Panther can't help but live in the present too. It's a quandary that keeps the band both timely and timeless. And there's an innocence to the four band members' bewilderment at modern life and basic social graces that is oddly relatable. The band's new album, Heavy Metal Rules , is another helping of meticulously crafted songs about sex, love and the greatest drug of all: heavy metal ( and cocaine). But the band explores new ground, too. "Always Gonna Be a Ho" and "I'm Not Your B---h" tackle the challenges of long-term

Achieving high pregnancy rates is an important goal in every cow-calf operation. After every breeding season, we either are satisfied with the results or wondering why our pregnancy rates were so low and focusing on ways to improve them. Traditional thinking trains us to be satisfied with our results when we have met the industry average, or are as good as, if not better than, our neighbor's pregnancy rates. Nontraditional thinking should redirect our focus more on the causes of some of these failures and on correcting or minimizing the problem. Reproductive failures can occur in any cow-calf operation and lead to a significant chunk of the financial loss incurred from that calf crop. Reproductive failures can occur in any cow-calf operation and account for a significant chunk of the financial loss incurred from a poor calf crop. Let's take a look at the top 5 reproductive failures that I believe are often seen in a cow-calf operation, beginning with No. 5 5. Leaving the

Edward W. Hook III The clinical trial design for testing new urogenital gonorrhea treatments needs to be re-evaluated, researchers said. Writing in Clinical Infectious Disease s, Edward W. Hook III, MD, endowed professor of infectious disease translational research in the departments of medicine, epidemiology and microbiology at the University of Alabama at Birmingham, and colleagues summarized the current state of clinical trials for gonorrhea therapies, as well as methods that may improve efficacy and increase the number of treatments under evaluation. Infectious Disease News spoke with Hook about the importance of trial design, its impact on new antimicrobials entering the market and the path future trials evaluating gonorrhea treatment should take. – by Marley Ghizzone Q: What prompted this paper? A: The long and the short of it is that we are in a period of crisis regarding sexually transmitted infections . Gonorrhea rates have gone up steadily for the past decade and t

When some of the nation’s top infectious disease specialists sound the alarm about a worrisome public health threat, one could be forgiven for assuming the topic is some frightening emerging infectious disease. However, in an editorial published this month in The Journal of Infectious Diseases , the warning isn’t about some scary new threat, but about a long-known and easily treatable one: sexually transmitted infections (STIs). “STIs represent a major public health crisis worldwide and in the United States with the incidence of gonorrhea, syphilis, chlamydia, and trichomoniasis increasing by over 1 million new, curable cases daily,” reports Anthony S. Fauci, MD, MPH, director of the National Institutes of Health’s (NIH) National Institute of Allergy and Infectious Diseases (NIAID), and colleagues, in the editorial. Fauci, Emily Erbelding, MD, MPH, NIAID’s Division of Microbiology and Infectious Diseases, and Robert W. Eisinger, PhD, former director of the NIH's Office of AIDS Re

When we talk about climate change, we make projections into the future — the number of degrees that will cause devastation by a certain year or the number of climate refugees we can expect by 2050. But infectious disease specialists remind us that, as a recent article in Foreign Affairs stated, " Climate Change is Already Killing Us ." That article and others detail how climate change is exacerbating disease, making public health one of the world's most immediate climate challenges. Infectious disease specialist Dr. Emily Shuman of the University of Michigan, Ann Arbor, says two major factors are involved in the spread of infectious disease. "One is the spread of infectious diseases that are spread by arthropod vectors, including mosquitoes and ticks," she says. "The other is the spread of diarrheal disease typically spread through poor sanitation." Shuman says the present — and possible future — health consequences of warming are "alread

The national Capital seems to be in the grip of vector-borne diseases with malaria and chikungunya cases registering an exponential rise. High number of dengue cases have also been reported. According to the latest Municipal Corporation of Delhi (MCD) data, 65 cases of dengue and 64 cases of malaria have been reported in last week alone. So far this year, Delhi has reported 282 cases of dengue and 368 cases of malaria. Last year, the city saw 308 cases of malaria. Chikungunya cases have also registered a rise. Some 13 cases were reported in the last one week, taking this year’s figure to 87. Last year, 79 chikungunya cases were reported in Delhi. These figures come in the middle of the Delhi government’s 10 hafte, 10 baje, 10 minute’ (10 weeks, 10’o clock, 10 minutes) campaign against mosquito-borne diseases. Delhi chief minister Arvind Kejriwal had on September 8 launched his special mass campaign under the name 10 hafte, 10 baje, 10 minute’ by inspecting his home for stagnant wat

Day after day, the headlines are full of news on malaria, and in recent times, the outlook has been looking more positive, with research breakthroughs that may one day make the disease a thing of the past. In further positive malaria news, a new research grant will help bring a diagnostic kit to life. A cool £1 million has been awarded by Japan’s Global Health Innovative Technology (GHIT) Fund to facilitate the production, testing and validation trials of the world’s first ever saliva-based rapid diagnostic test (RDT). The RDT uses technology that was developed out of research conducted by Professor Rhoel Dinglasan at the University of Florida in the US, and the new funding will enable the commercialisation process of the RDT to be completed. This will be done by South Africa-based medical technology startup Erada Technology Alliance. Rapid diagnostic tests are crucial in curtailing malaria So, what is this RDT, we hear you ask. Well, it’s an easy-to-use tool that incorporates

"The innovative technology and approaches of our newly awarded discovery and preclinical investments demonstrate GHIT's persistent aspiration for new innovations and a push to accelerate product development for neglected patients by bridging Japan and the world," said Ms. Catherine Kaseri Ohura, the CEO of GHIT. Currently, there are 47 ongoing projects, including 25 discovery, 16 preclinical and six clinical trials in the GHIT portfolio. (Appendix 3)  * USD1 = JPY106.43 , the approximate exchange rate on August 30, 2019 . The first of its kind in Japan, the  GHIT Fund  is an international public-private partnership between the Government of Japan , multiple pharmaceutical companies, the Bill & Melinda Gates Foundation, the Wellcome Trust, and the United Nations Development Programme (UNDP). The GHIT Fund invests and manages a portfolio of development partnerships aimed at neglected diseases, such as malaria, tuberculosis and neglected tropical diseases that af